[Table/Fig-3]:

Gender distribution of study group patients (n=100).

Gender	Amikacin group		Gentamycin group		p-value
	n	%	n	%
Male	24	48.0	25	50.0	0.725
Female	26	52.0	25	50.0
Total	50	100.0	50	100.0

n = number of patients, % = percentage.